We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12

Top Buys

1
GPGI
GPGI Inc
GPGI
+$11M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Top Sells

1
RPRX icon
Royalty Pharma
RPRX
+$32.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.66M
3
IHC
Independence Holding Company
IHC
+$3.1M
4
EPD icon
Enterprise Products Partners
EPD
+$2.77M
5
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$2.76M

Sector Composition

1 Healthcare 17.55%
2 Industrials 15.14%
3 Financials 14.94%
4 Materials 10.92%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONDS icon
26
Ondas Inc
ONDS
$3.79B
$4.96M 0.88%
679,752
+179,752
+36% +$963K
LSXMA
27
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.74M 0.84%
141,002
– –
AXP icon
28
American Express
AXP
$247B
$4.67M 0.83%
25,000
– –
CDXS icon
29
Codexis
CDXS
$196M
$4.12M 0.73%
200,000
– –
JPM icon
30
JPMorgan Chase
JPM
$912B
$4.09M 0.73%
30,000
– –
FNCH
31
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$4.08M 0.72%
27,014
– –
AENT icon
32
Alliance Entertainment
AENT
$293M
$3.95M 0.7%
400,000
– –
SONO icon
33
Sonos
SONO
$1.7B
$3.7M 0.66%
131,146
-51,805
-28% -$1.38M
CUE icon
34
Cue Biopharma
CUE
$117M
$2.69M 0.48%
18,400
+11,733
+176% +$2.49M
FAZE
35
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.23M 0.4%
225,000
– –
BRIV
36
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$2.19M 0.39%
225,000
– –
LBTYK icon
37
Liberty Global Class C
LBTYK
$3.52B
$1.8M 0.32%
69,618
– –
MXCT icon
38
MaxCyte
MXCT
$145M
$1.76M 0.31%
250,000
– –
MIST icon
39
Milestone Pharmaceuticals
MIST
$154M
$1.6M 0.28%
250,000
– –
HCAR
40
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$1.47M 0.26%
+150,000
New +$1.47M
DNTH icon
41
Dianthus Therapeutics
DNTH
$5.21B
$1.41M 0.25%
30,275
– –
COUR icon
42
Coursera
COUR
$1.62B
$1.24M 0.22%
+53,725
New +$1.1M
VVNT
43
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$1.23M 0.22%
181,892
-120,351
-40% -$858K
IRBT
44
DELISTED
iRobot
IRBT
$1.21M 0.21%
19,041
-20,230
-52% -$1.28M
VATE icon
45
INNOVATE Corp
VATE
$128M
$1.01M 0.18%
27,480
– –
PAGS icon
46
PagSeguro Digital
PAGS
$2.56B
$999K 0.18%
+49,829
New +$928K
XYZ
47
Block Inc
XYZ
$48.5B
$996K 0.18%
7,342
+5,492
+297% +$665K
TEKK
48
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
$986K 0.18%
100,000
– –
LRN icon
49
Stride
LRN
$3.73B
$985K 0.17%
27,124
-41,737
-61% -$1.39M
CRIS icon
50
Curis
CRIS
$9.71M
$921K 0.16%
967
+187
+24% +$239K
1
2
3 4 5

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 24% a quarter earlier, followed by Industrials and Financials.

  • Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
  • Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
  • Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.